-
Study aim
-
Determination and comparison of appetite, skin disorders and body composition in the intervention and control groups before and after the intervention
-
Design
-
Clinical trial with control group, with parallel group, double-blind, randomized,Single phase on 80 patients . For randomization we use SPSS software version 25
-
Settings and conduct
-
80 hemodialysis patients referred to the dialysis center of Isfahan Khorshid Hospital will be divided into two groups of 40 people. The studied variables will be measured in all individuals, then for twelve weeks one group with zinc gluconate supplement and the other group with placebo in two They will be complementary and after the complementary period, the variables will be measured and checked again.
-
Participants/Inclusion and exclusion criteria
-
Patients who have been on dialysis for at least 3 months,
Dialyze at least twice a week,
Do not smoke
No pregnancy and lactation
Lack of nutrition through antral and parenteral
No other diseases such as cancer,inflammatory diseases and advanced liver disease
Do not take calcium and vitamin D supplements
Do not take drugs that affect dependent variables
-
Intervention groups
-
Eligible written consent will be obtained from eligible individuals who wish to participate in the study. Individuals are also asked to complete a questionnaire on demographic information, medical history, and medications. Then, using SPSS software and based on the code assigned to each person, by stratified randomization by BMI (between 25-25 and 25-30) and gender are divided into two groups of intervention and control.
-
Main outcome variables
-
Zinc gluconate supplementation, appetite changes, skin lesions, body composition, serum zinc level